Literature DB >> 11910122

Isolation and characterization of stable mutants of Streptomyces peucetius defective in daunorubicin biosynthesis.

K S Vetrivel1, K Dharmalingam.   

Abstract

Daunorubicin and its derivative doxorubicin are antitumour anthracycline antibiotics produced by Streptomyces peucetius. In this study we report isolation of stable mutants of S. peucetius blocked in different steps of the daunorubicin biosynthesis pathway. Mutants were screened on the basis of colony colour since producer strains are distinctively coloured on agar plates. Different mutants showed accumulation of aklaviketone, epsilon-rhodomycinone, maggiemycin or 13-dihydrocarminomycin in their culture filtrates. These results indicate that the mutations in these isolates affect steps catalysed by dnrE (mutants SPAK and SPMAG), dnrS (SPFS and SPRHO) and doxA (SPDHC) gene products.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11910122     DOI: 10.1007/bf02811416

Source DB:  PubMed          Journal:  J Genet        ISSN: 0022-1333            Impact factor:   1.166


  11 in total

1.  Cloning and characterization of the Streptomyces peucetius dnrQS genes encoding a daunosamine biosynthesis enzyme and a glycosyl transferase involved in daunorubicin biosynthesis.

Authors:  S L Otten; X Liu; J Ferguson; C R Hutchinson
Journal:  J Bacteriol       Date:  1995-11       Impact factor: 3.490

2.  Genetics of actinorhodin biosynthesis by Streptomyces coelicolor A3(2).

Authors:  B A Rudd; D A Hopwood
Journal:  J Gen Microbiol       Date:  1979-09

3.  Purification, cloning, and DNA sequence analysis of a chitinase from an overproducing mutant of Streptomyces peucetius defective in daunorubicin biosynthesis.

Authors:  K S Vetrivel; S K Pandian; U Chaudhary; K Dharmalingam
Journal:  Can J Microbiol       Date:  2001-03       Impact factor: 2.419

4.  Microbial transformation of aklanonic acid, a potential early intermediate in the biosynthesis of anthracyclines.

Authors:  C Wagner; K Eckardt; G Schumann; W Ihn; D Tresselt
Journal:  J Antibiot (Tokyo)       Date:  1984-06       Impact factor: 2.649

5.  In vivo and in vitro bioconversion of epsilon-rhodomycinone glycoside to doxorubicin: functions of DauP, DauK, and DoxA.

Authors:  M L Dickens; N D Priestley; W R Strohl
Journal:  J Bacteriol       Date:  1997-04       Impact factor: 3.490

6.  Isolation of a chitinase overproducing mutant of Streptomyces peucetius defective in daunorubicin biosynthesis.

Authors:  K S Vetrivel; K Dharmalingam
Journal:  Can J Microbiol       Date:  2000-10       Impact factor: 2.419

7.  Enhanced antibiotic production by manipulation of the Streptomyces peucetius dnrH and dnmT genes involved in doxorubicin (adriamycin) biosynthesis.

Authors:  C Scotti; C R Hutchinson
Journal:  J Bacteriol       Date:  1996-12       Impact factor: 3.490

8.  Anthracycline metabolites from Streptomyces violaceus A262. I. Isolation of antibiotic-blocked mutants from Streptomyces violaceus A262.

Authors:  O Johdo; T Ishikura; A Yoshimoto; T Takeuchi
Journal:  J Antibiot (Tokyo)       Date:  1991-10       Impact factor: 2.649

9.  Nutrient effects on anthracycline production by Streptomyces peucetius in a defined medium.

Authors:  M L Dekleva; J A Titus; W R Strohl
Journal:  Can J Microbiol       Date:  1985-03       Impact factor: 2.419

10.  [Leukaemomycin-blocked mutants of Streptomyces griseus and their pigments].

Authors:  C Wagner; C Stengel; I Eritt; G Schumann; W F Fleck
Journal:  Z Allg Mikrobiol       Date:  1981
View more
  3 in total

1.  Transcriptome analysis of an antibiotic downregulator mutant and synergistic Actinorhodin stimulation via disruption of a precursor flux regulator in Streptomyces coelicolor.

Authors:  Seon-Hye Kim; Han-Na Lee; Hye-Jin Kim; Eung-Soo Kim
Journal:  Appl Environ Microbiol       Date:  2011-01-07       Impact factor: 4.792

2.  Interspecies DNA microarray analysis identifies WblA as a pleiotropic down-regulator of antibiotic biosynthesis in Streptomyces.

Authors:  Seung-Hoon Kang; Jianqiang Huang; Han-Na Lee; Yoon-Ah Hur; Stanley N Cohen; Eung-Soo Kim
Journal:  J Bacteriol       Date:  2007-04-06       Impact factor: 3.490

3.  An In silico Based Comparison of Drug Interactions in Wild and Mutant Human β-tubulin through Docking Studies.

Authors:  Selvaakumar Chellasamy; Sudheer M M Mohammed
Journal:  Avicenna J Med Biotechnol       Date:  2014-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.